Sintx Technologies (SINT) Total Debt Growth (1y) (2014 - 2026)
Powered by 
Analysis
Sintx Technologies (SINT) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.29% |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 134.13% |
| Dec 31, 2025 | 247.50% |
| Sep 30, 2025 | 159.50% |
| Jun 30, 2025 | -57.84% |
| Mar 31, 2025 | -76.62% |
| Dec 31, 2024 | -31.43% |
| Sep 30, 2024 | -52.20% |
| Jun 30, 2024 | -44.91% |
| Mar 31, 2024 | -55.40% |
| Dec 31, 2023 | -93.81% |
| Sep 30, 2023 | 33.51% |
| Jun 30, 2023 | 93.97% |
| Mar 31, 2023 | 191.20% |
| Dec 31, 2022 | 560.51% |
| Sep 30, 2022 | -57.72% |
| Jun 30, 2022 | -67.00% |
| Mar 31, 2022 | -53.86% |
| Dec 31, 2021 | -47.61% |
| Sep 30, 2021 | -33.52% |
| Jun 30, 2021 | -5.98% |